Publication | Closed Access

Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: Do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?

Hematological MalignancyDo Specific CytogeneticMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderHematologyImmunologyPathologyAdult T-cell Leukemia-lymphomaImmunotherapyOncologyMyeloid Neoplasia